|
New Resource
ASH 2024: Select Abstracts of Key Advances in AML
A comprehensive review of key abstracts from the 2024 ASH Annual Meeting highlighting advancements in treatment strategies, clinical outcomes, and innovative therapies in acute myeloid leukemia.
|
|
CE Education
Advances in Non-Intensive Therapies for AML: From CD47-Targeting to Combination Strategies and Beyond
Eytan M. Stein, MD; David Sallman, MD; Marion Subklewe, MD
Our panel of experts explore some of the most important developments in AML today, including the latest updates on bispecific and CAR T-cell therapies.
|
|
CE Education
Changing Standards and Evolving Strategies in AML Patients Unfit for Intensive Chemotherapy
Eytan M. Stein, MD; David Sallman, MD; Marion Subklewe, MD
Our panel of experts discuss current standards of care in AML, focusing on the ongoing challenges of treating patients who are unfit for intensive chemotherapy.
|
|
New Resource
New Advances in the Treatment of PNH
Key takeaways from the 29th European Hematology Association Congress, highlighting the potential to change or significantly improve clinical practice through novel mechanisms of action, new therapeutic combinations, or unique insights into patient management in PNH
|
|
New Resource
Optimizing Outcomes in AML Through Tailored Treatment Strategies
A summary of current and emerging treatment strategies, patient assessment, and the role of genetic testing in managing AML.
|
|
New Resource
EHA 2024: Select Abstracts of Key Advances in AML
A comprehensive review of key abstracts from the 29th European Hematology Association Congress highlighting advancements in treatment strategies, clinical outcomes, and innovative therapies in acute myeloid leukemia.
|
|
New Resource
ASCO 2024: Select Abstracts of Key Advances in AML
A comprehensive review of key abstracts highlighting advancements in treatment strategies, clinical outcomes, and innovative therapies in acute myeloid leukemia.
|
|
CE Education
Harnessing the Power of the Complement Pathway: Evolving Treatments and Improving Outcomes in PNH
Carlos de Castro, MD and Bhumika Patel, MD
|
